The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Nuclear receptor coregulators: modulators of pathology and therapeutic targets
Open accessAbstract
The nuclear receptor superfamily includes transcription factors that transduce steroid, thyroid and retinoid hormones and other ligands in conjunction with coregulators. To date, over 350 coregulators have been reported in the literature, and advances in proteomic analyses of coregulator protein complexes have revealed that a far greater number of coregulator-interacting proteins also exist. Coregulator dysfunction has been implicated in diverse pathological states, genetic syndromes and cancer. A hallmark of disease related to the disruption of normal coregulator function is the pleiotropic effect on animal physiology, which is frequently manifested as the dysregulation of metabolic and neurological systems. Coregulators have broad physiological and pathological functions that make them promising new drug targets for diseases such as hormone-dependent cancers. Advances in proteomics, genomics and transcriptomics have provided novel insights into the biology of coregulators at a system-wide level and will lead the way to a new understanding of how coregulators can be evaluated in the context of complex and multifaceted genetic factors, hormones, diet, the environment and stress. Ultimately, better knowledge of the associations that exist between coregulator function and human diseases is expected to expand the indications for the use of future coregulator-targeted drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MOLECULAR MECHANISMS OF ACTION OF STEROID/THYROID RECEPTOR SUPERFAMILY MEMBERS
Tsai, M.-J., & O'Malley, B. W. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.002315 · Cited by 2,932
Self-citationA Map of Recent Positive Selection in the Human Genome
Voight, B. F., Kudaravalli, S., Wen, X., & Pritchard, J. K. (2006) · PLoS Biology · doi:10.1371/journal.pbio.0040072 · Cited by 2,893
Hörlein, A. J., Näär, A. M., Heinzel, T., Torchia, J., Gloss, B., Kurokawa, R., Ryan, A., Kamei, Y., Söderström, M., Glass, C. K., et al. (1995) · Nature · doi:10.1038/377397a0 · Cited by 2,034
Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
Wells, J. A., & McClendon, C. L. (2007) · Nature · doi:10.1038/nature06526 · Cited by 1,960
A transcriptional co-repressor that interacts with nuclear hormone receptors
Chen, J. D., & Evans, R. M. (1995) · Nature · doi:10.1038/377454a0 · Cited by 1,763
Transcriptional paradigms in mammalian mitochondrial biogenesis and function
Scarpulla, R. C. (2008) · Physiological Reviews · doi:10.1152/physrev.00025.2007 · Cited by 1,666
Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP
Petrif, F., Giles, R. H., Dauwerse, H. G., Saris, J. J., Hennekam, R. C. M., Masuno, M., Tommerup, N., van Ommen, G.-J. B., Goodman, R. H., Peters, D. J. M., et al. (1995) · Nature · doi:10.1038/376348a0 · Cited by 1,217
Human genetic variation and its contribution to complex traits
Frazer, K. A., Murray, S. S., Schork, N. J., & Topol, E. J. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2554 · Cited by 1,073
Decreased Histone Deacetylase Activity in Chronic Obstructive Pulmonary Disease
Ito, K., Ito, M., Elliott, W. M., Cosio, B., Caramori, G., Kon, O. M., Barczyk, A., Hayashi, S., Adcock, I. M., Hogg, J. C., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041892 · Cited by 968
Histone Deacetylase 4 Controls Chondrocyte Hypertrophy during Skeletogenesis
Vega, R. B., Matsuda, K., Oh, J., Barbosa, A. C., Yang, X., Meadows, E., McAnally, J., Pomajzl, C., Shelton, J. M., Richardson, J. A., et al. (2004) · Cell · doi:10.1016/j.cell.2004.10.024 · Cited by 804
Therapeutic application of histone deacetylase inhibitors for central nervous system disorders
Kazantsev, A. G., & Thompson, L. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2681 · Cited by 711
Xu, J., Qiu, Y., DeMayo, F. J., Tsai, S. Y., Tsai, M.-J., & O'Malley, B. W. (1998) · Science · doi:10.1126/science.279.5358.1922 · Cited by 684
Self-citationUldry, M., Yang, W., St-Pierre, J., Lin, J., Seale, P., & Spiegelman, B. M. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.04.002 · Cited by 643
Shangary, S., & Wang, S. (2009) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.113006.094723 · Cited by 623
Lipin 1 is an inducible amplifier of the hepatic PGC-1α/PPARα regulatory pathway
Finck, B. N., Gropler, M. C., Chen, Z., Leone, T. C., Croce, M. A., Harris, T. E., Lawrence, J. C., & Kelly, D. P. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.08.005 · Cited by 554
Xu, J., Liao, L., Ning, G., Yoshida-Komiya, H., Deng, C., & O'Malley, B. W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120166297 · Cited by 534
Self-citationDeconstructing repression: evolving models of co-repressor action
Perissi, V., Jepsen, K., Glass, C. K., & Rosenfeld, M. G. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2736 · Cited by 532
Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci
Cooper, J. D., Smyth, D. J., Smiles, A. M., Plagnol, V., Walker, N. M., Allen, J. E., Downes, K., Barrett, J. C., Healy, B. C., Mychaleckyj, J. C., et al. (2008) · Nature Genetics · doi:10.1038/ng.249 · Cited by 531
Ito, K., Lim, S., Caramori, G., Cosio, B., Chung, K. F., Adcock, I. M., & Barnes, P. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132556899 · Cited by 512
Nuclear Receptor Coregulators: Judges, Juries, and Executioners of Cellular Regulation
Lonard, D. M., & O'Malley, B. W. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.08.012 · Cited by 494
Self-citationReview of the in Vivo Functions of the p160 Steroid Receptor Coactivator Family
Xu, J., & Li, Q. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0116 · Cited by 493
Roelfsema, J. H., White, S. J., Ariyürek, Y., Bartholdi, D., Niedrist, D., Papadia, F., Bacino, C. A., den Dunnen, J. T., van Ommen, G.-J. B., Breuning, M. H., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/429130 · Cited by 478
SRC-1 and TIF2 Control Energy Balance between White and Brown Adipose Tissues
Picard, F., Géhin, M., Annicotte, J.-S., Rocchi, S., Champy, M.-F., O'Malley, B. W., Chambon, P., & Auwerx, J. (2002) · Cell · doi:10.1016/s0092-8674(02)01169-8 · Cited by 444
Self-citationAnalysis of the Human Endogenous Coregulator Complexome
Malovannaya, A., Lanz, R. B., Jung, S. Y., Bulynko, Y., Le, N. T., Chan, D. W., Ding, C., Shi, Y., Yucer, N., Krenciute, G., et al. (2011) · Cell · doi:10.1016/j.cell.2011.05.006 · Cited by 432
Self-citationPIK3CA Mutations and Copy Number Gains in Human Lung Cancers
Yamamoto, H., Shigematsu, H., Nomura, M., Lockwood, W. W., Sato, M., Okumura, N., Soh, J., Suzuki, M., Wistuba, I. I., Fong, K. M., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5084 · Cited by 429
Ng, D., Thakker, N., Corcoran, C. M., Donnai, D., Perveen, R., Schneider, A., Hadley, D. W., Tifft, C., Zhang, L., Wilkie, A. O. M., et al. (2004) · Nature Genetics · doi:10.1038/ng1321 · Cited by 322
Williams, S. R., Aldred, M. A., Der Kaloustian, V. M., Halal, F., Gowans, G., McLeod, D. R., Zondag, S., Toriello, H. V., Magenis, R. E., & Elsea, S. H. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.07.011 · Cited by 302
Nuclear Receptor Coregulators and Human Disease
Lonard, D. M., Lanz, R. B., & O’Malley, B. W. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0012 · Cited by 302
Self-citationEk, J., Andersen, G., Urhammer, S. A., Gæde, P. H., Drivsholm, T., Borch-Johnsen, K., Hansen, T., & Pedersen, O. (2001) · Diabetologia · doi:10.1007/s001250100032 · Cited by 293
Cen, B., Selvaraj, A., Burgess, R. C., Hitzler, J. K., Ma, Z., Morris, S. W., & Prywes, R. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.18.6597-6608.2003 · Cited by 289
TNF-Alpha as a Therapeutic Target in Inflammatory Diseases, Ischemia- Reperfusion Injury and Trauma
Esposito, E., & Cuzzocrea, S. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709788803024 · Cited by 281
Lelliott, C. J., Medina-Gomez, G., Petrovic, N., Kis, A., Feldmann, H. M., Bjursell, M., Parker, N., Curtis, K., Campbell, M., Hu, P., et al. (2006) · PLoS Biology · doi:10.1371/journal.pbio.0040369 · Cited by 280
Relative Corticosteroid Insensitivity of Peripheral Blood Mononuclear Cells in Severe Asthma
Hew, M., Bhavsar, P., Torrego, A., Meah, S., Khorasani, N., Barnes, P. J., Adcock, I., & Fan Chung, K. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200512-1930oc · Cited by 271
Sonoda, J., Mehl, I. R., Chong, L.-W., Nofsinger, R. R., & Evans, R. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611623104 · Cited by 266
Schmid, K., Oehl, N., Wrba, F., Pirker, R., Pirker, C., & Filipits, M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0089 · Cited by 262
Coordinate transcriptional regulation of bile acid homeostasis and drug metabolism
Eloranta, J. J., & Kullak-Ublick, G. A. (2005) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.09.019 · Cited by 260
Louie, M. C., Zou, J. X., Rabinovich, A., & Chen, H.-W. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.12.5157-5171.2004 · Cited by 259
Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) Coactivator Activity by IκB Kinase
Wu, R.-C., Qin, J., Hashimoto, Y., Wong, J., Xu, J., Tsai, S. Y., Tsai, M.-J., & O'Malley, B. W. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.10.3549-3561.2002 · Cited by 257
Self-citationSRC-3 Is Required for Prostate Cancer Cell Proliferation and Survival
Zhou, H.-J., Yan, J., Luo, W., Ayala, G., Lin, S.-H., Erdem, H., Ittmann, M., Tsai, S. Y., & Tsai, M.-J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4076 · Cited by 246
Yoh, S. M. (1997) · Molecular Endocrinology · doi:10.1210/me.11.4.470 · Cited by 219
Rubinstein–Taybi syndrome: clinical and molecular overview
Roelfsema, J. H., & Peters, D. J. M. (2007) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399407000415 · Cited by 217
Yang, J. J. (2009) · JAMA · doi:10.1001/jama.2009.7 · Cited by 216
John, T., Liu, G., & Tsao, M.-S. (2009) · Oncogene · doi:10.1038/onc.2009.197 · Cited by 207
Lessons in Signaling and Tumorigenesis from Polyomavirus Middle T Antigen
Fluck, M. M., & Schaffhausen, B. S. (2009) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00009-09 · Cited by 179
Absence of the SRC-2 Coactivator Results in a Glycogenopathy Resembling Von Gierke's Disease
Chopra, A. R., Louet, J.-F., Saha, P., An, J., DeMayo, F., Xu, J., York, B., Karpen, S., Finegold, M., Moore, D., et al. (2008) · Science · doi:10.1126/science.1164847 · Cited by 161
Self-citationQuintás‐Cardama, A., Santos, F. P. D. S., & Garcia‐Manero, G. (2010) · Leukemia · doi:10.1038/leu.2010.276 · Cited by 156
Nishihara, E., Yoshida‐Komiya, H., Chan, C.-S., Liao, L., Davis, R. L., O’Malley, B. W., & Xu, J. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-01-00213.2003 · Cited by 145
Self-citationYamamoto, Y., Tsuzuki, S., Tsuzuki, M., Handa, K., Inaguma, Y., & Emi, N. (2010) · Blood · doi:10.1182/blood-2010-01-264432 · Cited by 143
Rodriguez, A. L., Tamrazi, A., Collins, M. L., & Katzenellenbogen, J. A. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030404c · Cited by 141
Donkor, J., Zhang, P., Wong, S. Y., O’Loughlin, L., Dewald, J. W., Kok, B. P., Brindley, D. N., & Reue, K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.023663 · Cited by 137
Histone Deacetylation: An Important Mechanism in Inflammatory Lung Diseases
Adcock, I. M., Ito, K., & Barnes, P. J. (2005) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550500346683 · Cited by 136
Rosiglitazone Treatment Prevents Mitochondrial Dysfunction in Mutant Huntingtin-expressing Cells
Quintanilla, R. A., Jin, Y. N., Fuenzalida, K. M., Bronfman, M., & Johnson, G. V. W. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804291200 · Cited by 128
Wang, S., Yuan, Y., Liao, L., Kuang, S.-Q., Tien, J. C.-Y., O’Malley, B. W., & Xu, J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808703105 · Cited by 127
Self-citationNuclear receptor drug discovery
Chen, T. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2008.07.001 · Cited by 126
Small Molecule Inhibition of the Steroid Receptor Coactivators, SRC-3 and SRC-1
Wang, Y., Lonard, D. M., Yu, Y., Chow, D., Palzkill, T. G., & O’Malley, B. W. (2011) · Molecular Endocrinology · doi:10.1210/me.2011-1222 · Cited by 122
Self-citationOncogenic steroid receptor coactivator-3 is a key regulator of the white adipogenic program
Louet, J., Coste, A., Amazit, L., Tannour‐Louet, M., Wu, R., Tsai, S. Y., Tsai, M., Auwerx, J. H., & O’Malley, B. W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608711103 · Cited by 118
Self-citationThe biology of PGC-1α and its therapeutic potential
Handschin, C. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.03.006 · Cited by 108
Multi-modulation of nuclear receptor coactivators through posttranslational modifications
Han, S. J., Lonard, D. M., & O’Malley, B. W. (2008) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2008.10.001 · Cited by 103
Self-citationChopra, A. R., Kommagani, R., Saha, P. K., Louet, J., Salazar, C., Song, J., Jeong, J., Finegold, M. J., Viollet, B., DeMayo, F. J., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2010.12.001 · Cited by 90
Self-citationKuwahara, K., Kinoshita, H., Kuwabara, Y., Nakagawa, Y., Usami, S., Minami, T., Yamada, Y., Fujiwara, M., & Nakao, K. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00154-10 · Cited by 90
Yi, P., Feng, Q. F., Amazit, L., Lonard, D. M., Tsai, S. Y., Tsai, M., & O’Malley, B. W. (2008) · Molecular Cell · doi:10.1016/j.molcel.2007.12.030 · Cited by 85
Self-citationPalma, T. D., D'Andrea, B., Liguori, G. L., Liguoro, A., de Cristofaro, T., Prete, D. D., Pappalardo, A., Mascia, A., & Zannini, M. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.10.016 · Cited by 80
Role of RIP140 in metabolic tissues: Connections to disease
White, R., Morganstein, D. L., Christian, M., Seth, A., Herzog, B., & Parker, M. G. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.11.017 · Cited by 71
Nuclear receptor coregulators as a new paradigm for therapeutic targeting
Hsia, E. Y. C., Goodson, M. L., Zou, J. X., Privalsky, M. L., & Chen, H.-W. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.09.016 · Cited by 70
TAZ/WWTR1 is overexpressed in papillary thyroid carcinoma
de Cristofaro, T., Palma, T. D., Ferraro, A., Corrado, A., Lucci, V., Franco, R., Fusco, A., & Zannini, M. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.11.008 · Cited by 70
Sanford, M., & Scott, L. J. (2009) · Drugs · doi:10.2165/10489100-000000000-00000 · Cited by 60
Cai, D., Shames, D. S., Raso, M. G., Xie, Y., Kim, Y. H., Pollack, J. R., Girard, L., Sullivan, J. P., Gao, B., Peyton, M., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0005 · Cited by 58
Multiple coregulatory control of tyrosine hydroxylase gene transcription
Reddy, S. D. N., Rayala, S. K., Ohshiro, K., Pakala, S. B., Kobori, N., Dash, P. K., Yun, S., Qin, J., O’Malley, B. W., & Kumar, R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101193108 · Cited by 53
Self-citationTargeting PGC-1α to control energy homeostasis
Wu, Z., & Boss, O. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.10.1329 · Cited by 52
Kadow, J. F., Wang, H.-G. H., & Lin, P. (2006) · PubMed · Cited by 48
PGC-1α Gly482Ser Polymorphism Associates With Hypertension Among Danish Whites
Andersen, G., Thørner, L. W., Jensen, D. P., Glümer, C., Tarnow, L., Drivsholm, T., Poulsen, P., Hansen, S. K., Nielsen, E.-M. D., Ek, J., et al. (2005) · Hypertension · doi:10.1161/01.hyp.0000158946.53289.24 · Cited by 46
K-ras as a Target for Lung Cancer Therapy
Adjei, A. A. (2008) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318174dbf9 · Cited by 45
Mettu, N. B., Stanley, T. B., Dwyer, M. A., Jansen, M. S., Allen, J. E., Hall, J. M., & McDonnell, D. P. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0201 · Cited by 44
Lonard, D. M., Kumar, R., & O’Malley, B. W. (2009) · Molecular Endocrinology · doi:10.1210/me.2009-0276 · Cited by 43
Self-citationFlågeng, M. H., Moi, L. L. H., Dixon, J. M., Geisler, J., Lien, E. A., Miller, W. R., Lønning, P. E., & Mellgren, G. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605324 · Cited by 43
Synthesis of Biphenyl Proteomimetics as Estrogen Receptor-α Coactivator Binding Inhibitors
Williams, A. B., Weiser, P. T., Hanson, R. N., Gunther, J. R., & Katzenellenbogen, J. A. (2009) · Organic Letters · doi:10.1021/ol901999f · Cited by 38
Charlier, T. D. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.05.004 · Cited by 37
Ablation of Steroid Receptor Coactivator-3 Resembles the Human CACT Metabolic Myopathy
York, B., Reineke, E. L., Sagen, J. V., Nikolai, B. C., Zhou, S., Louet, J., Chopra, A. R., Chen, X., Reed, G., Noebels, J. L., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.03.020 · Cited by 36
Self-citationTargeting Rho GTPases by Peptidic Structures
Marchioni, F., & Zheng, Y. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788682334 · Cited by 22
Combined detection of p53, p16, Rb, and EGFR mutations in lung cancer by suspension microarra
Ye, Y., Wang, D., Su, C., Rong, T., & Guo, A. (2009) · Genetics and Molecular Research · doi:10.4238/vol8-4gmr627 · Cited by 20
Erlotinib in non-small-cell lung cancer: a review of the clinical and economic evidence
Carlson, J. J. (2009) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/erp.09.49 · Cited by 15
Choi, H.-K., Choi, K., Oh, S.-Y., Kang, H., Lee, Y.-H., Haam, S., Ahn, Y., Kim, K., Kim, K., & Yoon, H. (2007) · Experimental & Molecular Medicine · doi:10.1038/emm.2007.60 · Cited by 14
Cited by
Estrogens, Neuroinflammation, and Neurodegeneration
Villa, A., Vegeto, E., Poletti, A., & Maggi, A. (2016) · Endocrine Reviews · doi:10.1210/er.2016-1007 · Cited by 423
Mechanisms of enhancer action: the known and the unknown
Panigrahi, A., & O’Malley, B. W. (2021) · Genome Biology · doi:10.1186/s13059-021-02322-1 · Cited by 350
Self-citationHu, M., Luo, Q., Alitongbieke, G., Chong, S., Xu, C., Xie, L., Chen, X., Zhang, D., Zhou, Y., Wang, Z., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.03.008 · Cited by 318
Molecular Control of Oligodendrocyte Development
Elbaz, B., & Popko, B. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2019.01.002 · Cited by 293
Estrogenic control of mitochondrial function
Klinge, C. M. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101435 · Cited by 293
Metadata
- Authors
- Lonard, D. M., & O'Malley, B. W.
- Venue
- Nature Reviews Endocrinology
- Published
- 2012-06-26
- Volume
- 8
- Issue
- 10
- Pages
- 598-604
- ISSN
- 1759-5029 (ISSN-L)
- 1759-5037
- OpenAlex
- W2018328431
- Cited by
- 272
- References
- 82
- FWCI
- 3.74
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.